• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转移性结肠癌的一种新型预后指数:预后免疫营养指数。

A Novel Prognostic Index for Metastatic Colon Cancer: The Prognostic Immune Nutritional Index.

作者信息

Kayikcioglu Erkan, Iscan Gokce

机构信息

Department of Medical Oncology, Suleyman Demirel University School of Medicine, Isparta, TUR.

Department of Family Medicine, Suleyman Demirel University School of Medicine, Isparta, TUR.

出版信息

Cureus. 2023 Jan 15;15(1):e33808. doi: 10.7759/cureus.33808. eCollection 2023 Jan.

DOI:10.7759/cureus.33808
PMID:36819360
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9931376/
Abstract

Objective Systemic inflammation and nutrition are associated with survival outcomes in metastatic colon cancer (mCC) patients. A new and strong prognostic marker named the Prognostic Immune Nutritional Index (PINI) was proposed as the best marker for outcomes in metastatic colon cancer patients. This study aimed to evaluate the prognostic significance of PINI in mCC patients. Methods The data of 190 patients who were admitted to our center and diagnosed with mCC between 2010 and 2020 abiding by our inclusion criteria were reviewed retrospectively. Receiver operating characteristic (ROC) analysis was used to identify the optimum cutoff value of PINI for overall survival (OS). Results The mean age of the participants was 62.64±11.99 years. The median follow-up time was 25.81 months. According to PINI, the median OS in patients who had PINI<3 was 22.70 months (95% confidence interval (CI): 16.05-29.35), and the median OS in patients who had PINI≥3 was 38.83 months (95% CI: 26.98-37.01) (p<0.001). PINI score lower than 3 was an independent prognostic indicator in multivariate analysis. Conclusions PINI was discovered to be an independent prognostic factor in metastatic colorectal cancer. We believe that PINI, which can be calculated using a simple formula, will provide clinicians with important clues when deciding on individual treatment.

摘要

目的 全身炎症和营养状况与转移性结肠癌(mCC)患者的生存结局相关。一种名为预后免疫营养指数(PINI)的新型强效预后标志物被提出,作为转移性结肠癌患者预后的最佳标志物。本研究旨在评估PINI在mCC患者中的预后意义。方法 回顾性分析2010年至2020年间符合纳入标准入住本中心并诊断为mCC的190例患者的数据。采用受试者工作特征(ROC)分析确定PINI对总生存期(OS)的最佳截断值。结果 参与者的平均年龄为62.64±11.99岁。中位随访时间为25.81个月。根据PINI,PINI<3的患者中位OS为22.70个月(95%置信区间(CI):16.05 - 29.35),PINI≥3的患者中位OS为38.83个月(95% CI:26.98 - 37.01)(p<0.001)。在多因素分析中,PINI评分低于3是独立的预后指标。结论 发现PINI是转移性结直肠癌的独立预后因素。我们认为,PINI可通过简单公式计算得出,在临床医生决定个体化治疗时将为其提供重要线索。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec4b/9931376/9ee8721c52ea/cureus-0015-00000033808-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec4b/9931376/9ee8721c52ea/cureus-0015-00000033808-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec4b/9931376/9ee8721c52ea/cureus-0015-00000033808-i01.jpg

相似文献

1
A Novel Prognostic Index for Metastatic Colon Cancer: The Prognostic Immune Nutritional Index.转移性结肠癌的一种新型预后指数:预后免疫营养指数。
Cureus. 2023 Jan 15;15(1):e33808. doi: 10.7759/cureus.33808. eCollection 2023 Jan.
2
Development and validation of a novel strong prognostic index for colon cancer through a robust combination of laboratory features for systemic inflammation: a prognostic immune nutritional index.通过稳健组合实验室特征进行全身炎症的新型结肠癌强预后指标的开发和验证:预后免疫营养指数。
Br J Cancer. 2022 Jun;126(11):1539-1547. doi: 10.1038/s41416-022-01767-w. Epub 2022 Mar 5.
3
Significance of the Prognostic Immune and Nutritional Index in Patients With Stage I-III Colorectal Cancer.I-III期结直肠癌患者预后免疫和营养指数的意义
Cancer Diagn Progn. 2023 May 3;3(3):354-359. doi: 10.21873/cdp.10223. eCollection 2023 May-Jun.
4
The prognostic value of the prognostic nutritional index in patients with metastatic colorectal cancer.预后营养指数在转移性结直肠癌患者中的预后价值。
Asia Pac J Clin Oncol. 2020 Oct;16(5):e179-e184. doi: 10.1111/ajco.13328. Epub 2020 Apr 16.
5
The Clinical Impact of the Prognostic Immune and Nutritional Index in Gastric Cancer Patients Who Received Curative Treatment.预后免疫和营养指数对接受根治性治疗的胃癌患者的临床影响。
Anticancer Res. 2024 May;44(5):2231-2238. doi: 10.21873/anticanres.17030.
6
The Prognostic Immune and Nutritional Indices Are Independent Prognostic Factors for Esophageal Cancer Patients Who Receive Curative Treatment.预后免疫和营养指标是接受根治性治疗的食管癌患者的独立预后因素。
Anticancer Res. 2024 May;44(5):2185-2192. doi: 10.21873/anticanres.17025.
7
A prognostic immune nutritional index can predict all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis.一种预后免疫营养指数可预测抗中性粒细胞胞浆抗体相关性血管炎患者的全因死亡率。
Ther Adv Musculoskelet Dis. 2023 Jul 29;15:1759720X231188818. doi: 10.1177/1759720X231188818. eCollection 2023.
8
Prognostic nutritional index predicts prognosis in patients with metastatic nasopharyngeal carcinoma.预后营养指数可预测转移性鼻咽癌患者的预后。
Onco Targets Ther. 2016 Sep 28;9:5955-5961. doi: 10.2147/OTT.S114382. eCollection 2016.
9
Prognostic value of PINI index in patients with multiple myeloma.PINI 指数在多发性骨髓瘤患者中的预后价值。
Eur J Haematol. 2012 Apr;88(4):306-13. doi: 10.1111/j.1600-0609.2011.01740.x. Epub 2012 Jan 4.
10
The usefulness of the prognostic inflammatory and nutritional index (PINI) in a haemodialysis population.在血液透析人群中,预后炎症和营养指数(PINI)的有用性。
Nutr Metab Cardiovasc Dis. 2009 Dec;19(11):811-5. doi: 10.1016/j.numecd.2009.01.009. Epub 2009 Apr 9.

引用本文的文献

1
Development and validation of predictive models for disease-free survival and overall survival in non-metastatic right-sided colon adenocarcinoma patients based on inflammatory and nutritional indices.基于炎症和营养指标的非转移性右半结肠癌患者无病生存期和总生存期预测模型的开发与验证
BMC Gastroenterol. 2025 Jul 21;25(1):527. doi: 10.1186/s12876-025-04107-3.
2
Usefulness of the preoperative Prognostic Immune and Nutritional Index as a prognostic predictor for patients with gastric cancer.术前预后免疫和营养指数作为胃癌患者预后预测指标的效用
Oncol Lett. 2025 Jul 8;30(3):435. doi: 10.3892/ol.2025.15181. eCollection 2025 Sep.
3

本文引用的文献

1
Clinical significance of baseline Pan-Immune-Inflammation Value and its dynamics in metastatic colorectal cancer patients under first-line chemotherapy.一线化疗转移性结直肠癌患者基线 Pan-Immune-Inflammation 值及其动态变化的临床意义。
Sci Rep. 2022 Apr 27;12(1):6893. doi: 10.1038/s41598-022-10884-8.
2
Pretreatment inflammatory markers predicting treatment outcomes in colorectal cancer.预测结直肠癌治疗结果的预处理炎症标志物
Ann Coloproctol. 2022 Apr;38(2):97-108. doi: 10.3393/ac.2021.01004.0143. Epub 2022 Mar 29.
3
Development and validation of a novel strong prognostic index for colon cancer through a robust combination of laboratory features for systemic inflammation: a prognostic immune nutritional index.
Novel tumor marker index combining carcinoembryonic antigen and carbohydrate antigen 19-9: New prognostic factor for metastatic colorectal cancer.
结合癌胚抗原和糖类抗原19-9的新型肿瘤标志物指数:转移性结直肠癌的新预后因素。
World J Gastrointest Oncol. 2025 May 15;17(5):104341. doi: 10.4251/wjgo.v17.i5.104341.
4
The prognostic value of immune-nutritional status in metastatic colorectal cancer: Prognostic Nutritional Index (PNI).免疫-营养状态在转移性结直肠癌中的预后价值:预后营养指数(PNI)。
Support Care Cancer. 2024 May 23;32(6):374. doi: 10.1007/s00520-024-08572-6.
5
Outcomes Following Pedestal Cup Reconstruction of (Impending) Pathological Fractures of the Acetabulum due to Metastatic Bone Disease.转移性骨病所致髋臼(即将发生的)病理性骨折行髋臼杯重建后的疗效
Indian J Surg Oncol. 2024 Jun;15(2):428-436. doi: 10.1007/s13193-024-01917-x. Epub 2024 Mar 16.
通过稳健组合实验室特征进行全身炎症的新型结肠癌强预后指标的开发和验证:预后免疫营养指数。
Br J Cancer. 2022 Jun;126(11):1539-1547. doi: 10.1038/s41416-022-01767-w. Epub 2022 Mar 5.
4
Prognostic Value of Pretreatment Prognostic Nutritional Index in Patients With Renal Cell Carcinoma: A Meta-Analysis.肾细胞癌患者治疗前预后营养指数的预后价值:一项Meta分析
Front Oncol. 2021 Oct 5;11:719941. doi: 10.3389/fonc.2021.719941. eCollection 2021.
5
Prognostic nutritional index as a prognostic factor in lung cancer patients receiving chemotherapy: a systematic review and meta-analysis.预后营养指数作为接受化疗的肺癌患者的预后因素:系统评价和荟萃分析。
Eur Rev Med Pharmacol Sci. 2021 Sep;25(18):5636-5652. doi: 10.26355/eurrev_202109_26783.
6
Prognostic Value of Platelet-to-Lymphocyte Ratio, Neutrophil-to-Lymphocyte Ratio, and Lymphocyte-to-White Blood Cell Ratio in Colorectal Cancer Patients Who Received Neoadjuvant Chemotherapy.血小板与淋巴细胞比值、中性粒细胞与淋巴细胞比值和淋巴细胞与白细胞比值对接受新辅助化疗的结直肠癌患者的预后价值。
Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211034291. doi: 10.1177/15330338211034291.
7
Prediction of Recurrence in Patients with Stage III Colon Cancer Using Conventional Clinicopathological Factors and Peripheral Blood Test Data: A New Analysis with Artificial Intelligence.利用常规临床病理因素和外周血检测数据预测 III 期结肠癌患者的复发:人工智能的新分析。
Oncology. 2021;99(5):318-326. doi: 10.1159/000513414. Epub 2021 Feb 24.
8
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
9
Prognostic nutritional index and postoperative outcomes in patients with colon cancer after laparoscopic surgery.腹腔镜手术后结直肠癌患者的预后营养指数与术后结局。
Surg Today. 2020 Dec;50(12):1633-1643. doi: 10.1007/s00595-020-02050-2. Epub 2020 Jun 17.
10
The prognostic value of the prognostic nutritional index in patients with metastatic colorectal cancer.预后营养指数在转移性结直肠癌患者中的预后价值。
Asia Pac J Clin Oncol. 2020 Oct;16(5):e179-e184. doi: 10.1111/ajco.13328. Epub 2020 Apr 16.